Through a comprehensive analysis integrating CIITA transcriptome expression correlation, chromatin accessibility features of genes in tsMHC-II high-expression tumor cells, and anthracycline treatment-related datasets, we identified that KAT2B induces chromatin accessibility and expression of the CIITA promoter via acetylation. The gene discussed is CIITA; the disease is neoplasm.